Diabetes insipidus is seldom complicated by other hormonal defects. As far as we know only one patient with diabetes insipidus and adrenal insufficiency has previously been described (Skillern, Corcoran, and Scherbel, 1956 ), although a number of patients with loss of both anterior and posterior pituitary function have been reported (Leaf, Mamby, Rasmussen, and Marasco, 1952; Engstrom and Liebman 1953; Lipsett and Pearson, 1957) . Because of the difficulties encountered in the management of combined diabetes insipidus and adrenal insufficiency, the following case is recorded.
Case Report
In 1947 a married woman, aged 54, developed carcinoma of the left breast, which was treated by radical mastectomy and local irradiation. She remained well until March, 1957, when malaise, loss of weight, and widespread bone pain developed. There was no local recurrence, but radiographs revealed extensive pulmonary and osseous metastases, particularly involving the femora, pelvis, and skull with erosion of the sella turcica. After oophorectomy and total adrenalectomy, performed by Sir Stanford Cade, the patient's post-operative course was uneventful and she was discharged in May, 1957, taking The history of thirst and polyuria together with the dehydration and haemoconcentration indicated diabetes insipidus, and treatment with vasopressin (" pitressin ") was started. The serum potassium concentration was low in contrast with the high serum sodium and chloride levels, and an electrocardiogram showed changes of moderate hypokalaemia. This hypokalaemia was attributed to the large doses of cortisone which the patient had been taking. Over the next 12 hours 3.5 1. of fluid and 90 mEq of potassium were given orally with an additional 125 mg. cortisone, making a total of 175 mg. on this day. The patient improved rapidly and became mentally alert. The dehydration disappeared and the blood pressure became normal with weight gain, a positive fluid balance, and a fall in plasma protein and serum sodium levels. By the third day her clinical state was satisfactory and the extracellular fluid volume, as measured by the bromide space (Nicholson and Zilva, 1957) , had expanded by nearly 4 litres to 16.5 litres, correlating closely with the cumulative fluid gain (Fig. 1) . At this stage the bromide space was probably a reliable measure of the extracellular fluid volume and was within the normal range for the patient's height and weight.
During this time she had received 1 ml. " pitressin" tannate in oil intramuscularly each day (5 pressor units/ml.), but from the fourth day onwards she deteriorated unexpectedly so that by the eighth day the weight and bromide space had fallen to the same levels as on entry, despite increasing the " pitressin " to 1.5 ml. daily on Day 7. It was then discovered that aqueous "pitressin " (20 pressor units/ml.) had been given in error for the oily suspension of " pitressin " tannate, and, despite a sixfold increase in dosage, had produced no effective overall antidiuretic response. Fig. 1 shows that when this error was corrected the diabetes insipidus was once again controlled. daily, and the average urine volume on Days I and 2 was 3,730 ml. (Table 1 ), indicating that the diabetes was not completely controlled. On Day 3 the dose of " pitressin" tannate was increased to 2 units daily. The effect of this was delayed but was followed by an increase in blood pressure and in urinary sodium excretion. On the first day of this dosage the urine volume increased to 5 1. and was associated with haemoconcentration, as shown by the rise in serum sodium and plasma protein concentrations on Days 3 and 4. On the fourth day the urine volume fell and thereafter better control of the diabetes insipidus was obtained, judging from the urine volume, gain in weight, and return of the serum sodium and plasma protein levels to normal. Reducing the dose of " pitressin " tannate to 1 unit daily on Day 8 was accompanied by a gradual fall in sodium excretion and a gradual increase in urinary volume, suggesting that this dose did not quite control the diabetes insipidus. The pattern of these responses showed that there was some delay in the absorption of pitressin" tannate in oil from the site of injection. Thus the maximum effect of 2 units daily was not evident for 24 to 48 hours and the increased diuresis caused by halving the dose of "pitressin" on Day 8 was delayed for a similar period.
On Day 2 the total exchangeable sodium, measured with radiosodium, was 3,450 mEq (54 mEq/kg. body weight), an abnormally high figure. The total exchangeable potassium at the end of the study was abnormally low at 1,280 mEq (21 mEqjkg. body weight). These findings suggested that the amount of adrenocortical substitution therapy was excessive, and the dose of fluorohydrocortisone was reduced after Day 10 to 0.1 mg. daily. Later the dose of cortisone was increased to 150 mg. daily, but this did not influence the response to a constant amount of pitressin " tannate. As a result of adrenalectomy and destruction of the neurohypophysis, the hormonal control of both salt and water balance was lost. Thus initially, whilst receiving large doses of cortisone but deficient in antidiuretic hormone, sodium was retained despite the polyuria, and the clinical picture was that of water depletion. At this stage the patient resembled the case described by Engstrom and Liebman (1953) in whom diabetes insipidus complicated anterior pituitary failure. However, by Day 3 (Fig. 1) (Biggart and Alexander, 1939; Ingram and Winter, 1938;  Gaunt, Birnie, and Eversole, 1949) . This fall in urine volume, despite continuing lack of antidiuretic hormone (ADH), is probably due to several factors, particularly a decrease in the solute-load requiring excretion and the reduction in glomerular filtration rate. Leaf and his associates (1952) showed in a patient with loss of both anterior and posterior pituitary function that lack of ADH, as shown by an inability to elaborate a concentrated urine, persisted, and the absence of polyuria depended upon the reduction in solute load. When this was increased the polyuria recurred, and when the solute load was kept constant cortisone had no effect on water excretion. These findings suggest that the influence of cortisone on the polyuria was due to its general metabolic effect which led to an increase in solute excretion.
Discussion
Cortisone also increases urine flow in patients with adrenocortical insufficiency by increasing the glomerular filtration rate. Burston and Garrod (1952) 
Influence of Antidiuretic Hormone on
Electrolyte Excretion There are many conflicting reports on the effect of " pitressin " on sodium and chloride excretion depending partly on species variation and partly on the degree of preliminary hydration. In normal subjects " pitressin " does not affect sodium output (Black and Thomson, 1951 ) though at low rates of urine flow a slight fall in sodium excretion may occur (Murphy and Stead, 1951) . Under artificial conditions, when the extracellular fluid volume is expanded by pitressin a delayed sodium diuresis results (Leaf, Bartter, Santos, and Wrong, 1953) . This is accompanied by potassium retention and is attributed to secondary inhibition of aldosterone production (Liddle, Bartter, Duncan, Barber, and Delea, 1955; Wrong, 1956 ).
In the case of anterior and posterior pituitary failure reported by Engstrom and Liebman (1953) "pitressin'' had no effect on sodium excretion, and, though Leaf et al. (1952) comment on the natriuresis produced by " pitressin " in their patient, this effect took three days to become fully apparent. It was probably not a direct effect of " pitressin " but due to secondary inhibition of sodium-retaining mechanisms.
The variation in urinary sodium and chloride excretion with " pitressin " dosage in the patient being discussed, on fixed doses of adrenocortical steroid, is therefore surprising. There is some day-to-day variation within the periods and the findings must be viewed with some suspicion. The diet, however, was constant and potassium excretion was fairly uniform throughout. She was adequately hydrated at the beginning of the investigation and the dose of cortisone and 9a-fluorohydrocortisone seemed adequate. Some support to the findings is given by the fact that after adrenalectomy she was adequately maintained on 50 mg. cortisone orally, whereas, when receiving "pitressin," double this dose did not prevent sodium depletion (Days 10-11, see Fig. 1 ).
The increase in sodium excretion was not delayed, was not accompanied by potassium retention, and therefore cannot be explained by changes in sodium-retaining hormones. In the presence of severe renal disease sodium excretion may vary with the blood pressure as a result of changes in renal plasma flow. In this patient renal function was normal (blood urea 27 mg.% on Day 2), and this mechanism seems unlikely. Furthermore, Murphy and Stead (1951) have shown that " pitressin " in physiological doses does not affect renal plasma flow or glomerular filtration. It may be that the increased sodium excretion is a direct effect of " pitressin," normally masked by simultaneous changes in sodiumretaining mechanisms, an explanation which is physiologically acceptable but without supporting experimental evidence.
This combination of endocrine defects proved difficult to treat, especially as sodium depletion may be masked by the diabetes insipidus. If a satisfactory preparation of " pitressin " is used, water balance is readily restored and steroid dosage must then be adjusted according to the serum electrolytes and urinary sodium excretion. Summary A patient* is reported in whom diabetes insipidus developed following total adrenalectomy for carcinomatosis.
During treatment syndromes of sodium and water depletion were seen which varied independently.
Aqueous " pitressin " was of no value in treatment even in high dosage, whereas oily " pitressin " tannate was very satisfactory.
An unusually high dosage of steroid was required for maintenance.
Sodium excretion appeared to vary with " pitressin " dosage.
